Repurposing chemotherapy-induced peripheral neuropathy grading.

Roser Velasco Haralabos P KalofonosDavid R CornblathPere Bruna Paola AlbertiEmanuela RossiIngemar S J MerkiesDimitri PsimarasChiara BrianiRoy I LalisangAngelo SchenoneGuido CavalettiJordi Brunanull null

Published in: European journal of neurology (2024)

Our results confirm the heterogeneity in CIPN perception between patients and physicians and identify three well-differentiated subgroups of patients delineated by degree of CIPN impairment based on scores derived from TNSc and QLQ-CIPN20. A more refined assessment of CIPN could potentially be achieved using the calculator tool derived from the cluster equations in this study. This tool, which facilitates individual patient classification, requires prospective validation.

Keyphrases

chemotherapy induced
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
primary care
peritoneal dialysis
prognostic factors
deep learning
patient reported outcomes